| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +100.00% | -17.77% | +0.17% | -17.93% | -18.60% | — |
| 14d | 5 | +100.00% | -19.27% | +0.78% | -20.05% | -17.67% | — |
| 30d | 5 | +100.00% | -21.54% | +3.01% | -24.54% | -25.00% | — |
| 60d | 5 | +80.00% | -26.05% | +4.17% | -30.22% | -35.08% | — |
| 90d | 5 | +80.00% | -23.23% | +6.38% | -29.61% | -33.22% | — |
| 180d | 5 | +100.00% | -41.88% | +10.59% | -52.47% | -54.81% | — |
| 1y | 5 | +100.00% | -31.92% | -2.56% | -29.36% | -34.01% | — |
| 2y | 5 | +100.00% | -56.22% | +4.66% | -60.88% | -64.47% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 2,631 | $16.98 | $44.7K | 147,447 | Jul 13, 2021 | Jul 14, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 6,000 | — | — | 150,078 | Jul 2, 2021 | Jul 7, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 6,000 | — | — | 6,000 | Jul 2, 2021 | Jul 7, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 6,800 | $22.26 | $151.4K | 144,078 | Jun 2, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 31,114 | $21.50 | $668.8K | 150,878 | Jun 2, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 9,115 | $22.71 | $207.0K | 186,877 | Jun 1, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 87,500 | — | — | 195,992 | Jun 1, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,885 | $23.57 | $115.1K | 181,992 | Jun 1, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 87,500 | — | — | 0 | Jun 1, 2021 | Jun 2, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 8,297 | — | — | 110,772 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 8,297 | — | — | 24,892 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 2,280 | $23.25 | $53.0K | 108,492 | Mar 2, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 99,500 | — | — | 99,500 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,400 | — | — | 28,400 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 20,600 | — | — | 108,135 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 20,600 | — | — | 41,200 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 5,660 | $24.06 | $136.2K | 102,475 | Mar 1, 2021 | Mar 3, 2021 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 6,000 | — | — | 88,895 | Jul 2, 2020 | Jul 7, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 6,000 | — | — | 12,000 | Jul 2, 2020 | Jul 7, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 1,360 | $1.50 | $2.0K | 87,535 | Jul 2, 2020 | Jul 7, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 24,045 | $1.32 | $31.7K | 82,895 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 87,500 | — | — | 106,940 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 87,500 | — | — | 87,500 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 20,600 | — | — | 24,952 | Mar 2, 2020 | Mar 4, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 5,512 | $1.26 | $6.9K | 19,440 | Mar 2, 2020 | Mar 4, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | SALE Chief Medical Officer | 20,600 | — | — | 61,800 | Mar 2, 2020 | Mar 4, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 116,160 | — | — | 116,160 | Mar 2, 2020 | Mar 4, 2020 ↗ |
| ACRS ACLARIS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 33,189 | — | — | 33,189 | Mar 2, 2020 | Mar 4, 2020 ↗ |